This inventor holds 1 USPTO granted patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Thomas Koch: Innovator in Nucleic Acid Sequencing
Introduction
Thomas Koch is a prominent inventor based in Penzberg, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid sequencing. His innovative work has paved the way for advancements in genetic analysis and diagnostics.
Latest Patents
Thomas Koch holds a patent for the invention titled "De-novo sequencing of nucleic acids." This invention is directed to an improved analysis procedure for the comparative sequencing of nucleic acids using multistage mass spectrometry. More precisely, the invention enables the de-novo sequencing of nucleic acid molecules, enhancing the accuracy and efficiency of genetic analysis.
Career Highlights
Koch is currently associated with Roche Molecular Systems, Inc., a leading company in the field of molecular diagnostics. His work at Roche has allowed him to apply his innovative ideas in a practical setting, contributing to the development of cutting-edge technologies in the healthcare sector.
Collaborations
Throughout his career, Thomas Koch has collaborated with notable colleagues, including Roderic Fuerst and Uwe Kobold. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Thomas Koch's contributions to nucleic acid sequencing exemplify the impact of innovation in molecular biology. His work continues to influence the field and improve diagnostic techniques, showcasing the importance of inventors in advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
